Brands: Auryxia · Tetraferric Tricitrate Decahydrate
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | generic | 1 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | generic | 1 | SUPPLYING |
| Akebia Therapeutics, Inc. | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC
CGMP Deviations — Recalling firm: Akebia Therapeutics dba Keryx Biopharmaceutials, Inc — The product was distributed by two major distributors who further distributed the product nationwide and one specialty …
cGMP deviations: Lots recalled were not manufactured in conformance with the FDA-approved manufacturing process for Auryxia. — Recalling firm: Keryx Biopharmaceuticals, Inc. — Nationwide in the U.S.
Presence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant potentially allowing the silica gel granules to make contact with Auryxia tablets in the bottle. — Recalling firm: Keryx Biopharmaceuticals, Inc. — Distributed nationwide in the USA
